Month: June 2018

IsoRay Announces Entry into Employment Agreement with Lori A. Woods as Interim CEO

Chairman of the Board Mick McCormick stated, “The Board and employees have high confidence in Lori Woods that has been built through the years that she has served at IsoRay.

Prostate Cancer News Today: “Prostate Cancer Patients Treated with Radioactive Seeds Retain Urinary, Bowel Quality”

The study, “Long-term Quality of Life in Prostate Cancer Patients Treated with Cesium-131,” was published in the Journal of Radiation Oncology, Biology, Physics and was recently featured by Prostate Cancer News Today contributor Daniela Semedo.

IsoRay Announces the Resignation of Chairman and CEO Thomas LaVoy; Industry Veteran Lori Woods Appointed Interim CEO; Mick McCormick Appointed Chairman of the Board

While the Company conducts a search for a new Chief Executive Officer, industry veteran Lori Woods has been appointed interim Chief Executive Officer, effective June 4, 2018.

Scroll to top